Investigator

Mukherjee Sanjukta

Assistant Professor (adjunct) · ISIR, Osaka University, Department of Regulatory Bioorganic Chemistry

MSMukherjee Sanjukta
Papers(1)
CD24 gene inhibition …
Collaborators(2)
Paul NayimVictor Kuete
Institutions(2)
Thrombosis Research I…Universit De Dschang

Papers

CD24 gene inhibition and TIMP-4 gene upregulation by Imperata cylindrica's root extract prevents metastasis of CaSki cells via inhibiting PI3K/Akt/snail signaling pathway and blocking EMT

Imperata cylindrica (L.) Raeusch (Gramineae) is a medicinal spice traditionally used in the treatment of hypertension and cancer. To assess the anti-metastatic potential of the methanol extract of I. cylindrica roots and determined its mechanisms of action. The growth inhibition activity of I. cylindrica root extract in vitro and in vivo in human cervical cancer. The scratch assay and Boyden Chamber assay were used to determine the anti-migrative and anti-invasion actions of the plant extract. The whole-genome gene expression profiling using RNA-Seq was performed to determine the differentially expressed genes in CaSki cells after exposure to I. cylindrica to identify its targeted genes related to metastasis. Using protein analysis (western blotting) and gene expression analysis (RTqPCR), the targeted pathways of the key genes that were initially identified with RNA-Seq, were evaluated. I. cylindrica extract showed dose-dependent cytotoxicity in vitro and in vivo in mice bearing tumors. Furthermore, I. cylindrica root extract significantly inhibited cell migration and cell invasion. After the genome-wide transcriptome analysis, we found that important genes involved in cancer progression and metastasis of cervical cancer, that is, CD24 and TIMP-4 were significantly downregulated and upregulated, respectively. Moreover, I. cylindrica root extract significantly inhibited the PI3/AKT/Snail signaling pathway and blocked the EMT of CaSki cells. These findings provide an anti-metastatic mechanism of action of I. cylindrica root extract toward the human cervical cancer suggesting that this plant maybe developed into selective chemotherapy.

16Works
1Papers
2Collaborators

Positions

2020–

Assistant Professor (adjunct)

ISIR, Osaka University · Department of Regulatory Bioorganic Chemistry

2017–

NCBS-Campus Fellow

National Centre for Biological Science-Tata Institute of Fundamental Research (NCBS-TIFR) · Cellular Organization and Signalling

2017–

Guest researcher

ISIR, Osaka University · Department of Regulatory Bioorganic Chemistry

2015–

Specially Appointed Assistant Professor

ISIR, Osaka University · Department of Regulatory Bioorganic Chemistry

2013–

Postdoctoral Fellow

ISIR, Osaka University · Department of Regulatory Bioorganic Chemistry

2013–

Research Scientist

Chemgen Pharma International Pvt. Ltd.,

2003–

Project fellow to Senior Research Chemist

Chembiotek Research International Pvt. Ltd (TCG Lifesciences)